These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21604586)

  • 21. [A single tablet against HIV: new combination preparation improves therapy].
    Pommer P
    Dtsch Med Wochenschr; 2012 Aug; 137(34-35):1673. PubMed ID: 22893044
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients: week-192 overall and subgroup analyses from STARTMRK.
    DeJesus E; Rockstroh JK; Lennox JL; Saag MS; Lazzarin A; Zhao J; Wan H; Rodgers AJ; Walker ML; Miller M; DiNubile MJ; Nguyen BY; Teppler H; Leavitt R; Sklar P;
    HIV Clin Trials; 2012; 13(4):228-32. PubMed ID: 22849964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction therapy with enfuvirtide-based highly active antiretroviral therapy in a patient with acute HIV-1 infection.
    Polk C; Chan-Tack KM; Kopack AM; Amoroso A
    AIDS Patient Care STDS; 2007 Feb; 21(2):75-7. PubMed ID: 17328655
    [No Abstract]   [Full Text] [Related]  

  • 24. A once-daily combination tablet (Atripla) for HIV.
    Med Lett Drugs Ther; 2006 Sep; 48(1244):78-9. PubMed ID: 17001298
    [No Abstract]   [Full Text] [Related]  

  • 25. First of a kind in HIV treatment.
    FDA Consum; 2006; 40(6):34. PubMed ID: 17333565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Once-daily dosing and the treatment of HIV disease.
    Laurence J
    AIDS Read; 2006 Sep; 16(9):444-5. PubMed ID: 17024761
    [No Abstract]   [Full Text] [Related]  

  • 27. Elvucitabine data released at CROI.
    AIDS Patient Care STDS; 2010 Mar; 24(3):198. PubMed ID: 20235383
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent FDA approvals and changes.
    AIDS Patient Care STDS; 2010 Feb; 24(2):133-4. PubMed ID: 20156092
    [No Abstract]   [Full Text] [Related]  

  • 29. Raltegravir as effective as efavirenz in 144-week data.
    AIDS Patient Care STDS; 2009 Aug; 23(8):679-80. PubMed ID: 19694035
    [No Abstract]   [Full Text] [Related]  

  • 30. Cost-effectiveness analysis of emtricitabine/tenofovir versus lamivudine/zidovudine, in combination with efavirenz, in antiretroviral-naive, HIV-1-infected patients.
    Sánchez-de la Rosa R; Herrera L; Moreno S
    Clin Ther; 2008 Feb; 30(2):372-81. PubMed ID: 18343275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-tablet Quad regimen achieves high rate of virologic suppression.
    AIDS Patient Care STDS; 2010 Mar; 24(3):197. PubMed ID: 20214488
    [No Abstract]   [Full Text] [Related]  

  • 32. Modified directly observed therapy to improve HIV treatment outcomes: little impact with potent, once-daily therapy in unselected antiretroviral-naïve patients.
    Bangsberg DR
    Curr HIV/AIDS Rep; 2009 Nov; 6(4):173-4. PubMed ID: 19849959
    [No Abstract]   [Full Text] [Related]  

  • 33. Tenofovir-emtricitabine-efavirenz in HIV-I-infected adults in Senegal: a 96-week pilot trial in treatment-naive patients.
    Landman R; Poupard M; Diallo M; Ngom Gueye NF; Diakhate N; Ndiaye B; Toure Kane C; Trylesinski A; Diop H; Mboup S; Koita Fall MB; Delaporte E; Benalycherif A; Girard PM; Sow PS
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(6):379-84. PubMed ID: 19755618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Once-daily single-tablet regimens: a long and winding road to excellence in antiretroviral treatment.
    Llibre JM; Clotet B
    AIDS Rev; 2012; 14(3):168-78. PubMed ID: 22833060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The first once-daily single-tablet regimen for the treatment of HIV-infected patients.
    Killingley B; Pozniak A
    Drugs Today (Barc); 2007 Jul; 43(7):427-42. PubMed ID: 17728844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Collaboration begins on combined drug.
    AIDS Patient Care STDS; 2005 Feb; 19(2):129. PubMed ID: 15747431
    [No Abstract]   [Full Text] [Related]  

  • 37. [Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].
    Bayonne Kombo ES; Gathse A
    Med Mal Infect; 2013 Mar; 43(3):134-5. PubMed ID: 23434355
    [No Abstract]   [Full Text] [Related]  

  • 38. [Analysis of adherence and efficiency when replacing an antiretroviral therapy with efavirenz-emtricitabine-tenofovir in a single daily dose].
    García-Ramos SE; Santolaya Perrín MR; Fernández-Pacheco García-Valdecasas M
    Farm Hosp; 2012; 36(5):315-20. PubMed ID: 22858089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New once-daily HIV combination better tolerated.
    Expert Rev Anti Infect Ther; 2004 Dec; 2(6):826. PubMed ID: 15566325
    [No Abstract]   [Full Text] [Related]  

  • 40. Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results.
    Gallant JE; Koenig E; Andrade-Villanueva J; Chetchotisakd P; DeJesus E; Antunes F; Arastéh K; Moyle G; Rizzardini G; Fehr J; Liu Y; Zhong L; Callebaut C; Szwarcberg J; Rhee MS; Cheng AK
    J Infect Dis; 2013 Jul; 208(1):32-9. PubMed ID: 23532097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.